ZCA
STJ

Zeke Capital Advisors’s St Jude Medical STJ Stock Holding History

Zeke Capital Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,518
Closed -$202K – 281
2016
Q4 		$202K Buy
+2,518
New +$200K 0.05% 191

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Zeke Capital Advisors's STJ Position: Q1 2017 in Review

Zeke Capital Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,518 shares — an estimated $202K sold.

Zeke Capital Advisors first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $202K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Zeke Capital Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Zeke Capital Advisors sold 2,518 St Jude Medical shares in Q1 2017, an estimated $202K.
  • Zeke Capital Advisors first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • Zeke Capital Advisors's St Jude Medical position peaked at $202K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Zeke Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.